PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Translational Antiviral Research, Georgia State University, Atlanta, GA 30303, USA.\', \'Texas Biomedical Research Institute, San Antonio, TX 78227, USA.\', \'Emory Institute for Drug Development, Emory University, Atlanta, GA 30322, USA.\', \'Drug Innovation Ventures at Emory (DRIVE), Atlanta, GA 30322, USA.\', \'Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.\', \'Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/science.abj5508
?:doi
?:hasPublicationType
?:journal
  • Science (New York, N.Y.)
is ?:pmid of
?:pmid
?:pmid
  • 34855509
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • 4\'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34855509>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34855509>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all